Latest Us Expansion News

Clinuvel Pharmaceuticals reports steady financial growth with an 8% rise in revenue and 2% profit increase, while expanding its US commercial footprint and completing recruitment for a pivotal vitiligo trial.

BetMakers Technology Group delivered a strong FY25 with a 5.6% half-on-half revenue growth and record profitability, while advancing its technology transformation and signing a strategic acquisition in Nevada.

Adveritas Limited reported a robust 89% increase in revenue to $7.84 million for FY25, driven by expanding customer contracts and product enhancements, while reducing its net loss by 39%. The company raised $8.5 million to fuel US expansion and new verticals.

Cyclopharm Limited reported a 26% revenue increase for the half year ended June 2025, driven by rapid US market expansion and strong growth in its Third-Party distribution business. Despite a wider net loss, the company secured a key patent extension and reaffirmed its target to install 250-300 Technegas® systems in the US by late 2026.

archTIS Limited has reported FY25 results with solid ARR growth and completed a transformative acquisition of Spirion LLC, significantly boosting its US market presence and product suite. The company is raising $20.5 million to fund this expansion and accelerate growth.

Compumedics has reported record-breaking sales orders and revenues for FY25, driven by strong US market growth and SaaS adoption, setting the stage for an ambitious FY26 expansion.

IRIS Metals has confirmed high-grade lithium mineralisation at its Edison Project in South Dakota, revealing promising drill results that bolster its US development ambitions. The company plans further drilling and an economic study to advance its lithium portfolio.

Carnegie Clean Energy reported a $2.33 million net loss for FY2025 but made significant strides in commercialising its wave energy technologies, supported by new loans and a US subsidiary launch.

Cobram Estate Olives Limited has reported record financial results for FY2025, driven by strong sales growth in Australia and a doubling of branded sales in the USA. The company is shifting its capital expenditure focus to expand its Californian operations while maintaining sustainable growth in Australia.

Cobram Estate Olives Limited (ASX – CBO) delivered a record FY2025 with a 167.8% surge in net profit and doubled US branded sales, underpinning its growth strategy and sustainability commitments.

Guzman y Gomez (GYG) has reported record FY25 results, surpassing $1.18 billion in global network sales and delivering a 45.5% increase in EBITDA. The company also declared its maiden fully-franked dividend, signaling confidence in sustained growth.

Zip Co Limited’s FY25 results reveal a powerful US market expansion driving a 147% rise in cash earnings and a strategic Nasdaq dual listing consideration.